Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics

Pan-cancer proteogenomics reveals potential drug targets

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets.

June 28, 2024

Vol.50 No.26

Clinical Trials & Tribulations

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

In May, the American Society of Clinical Oncology released guidelines on the use of germline genetic testing panels in concert with tumor testing for cancer patients. xxx:more

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.

March 29, 2024

Vol.50 No.13

In Brief

Kristin Heath named executive director of the UF Health Proton Therapy Institute

Kristin A. Heath was named executive director of the University of Florida Health Proton Therapy Institute. Kristin A. Heath succeeds Stuart L. Klein, who retired in November 2023 after 18 years.

January 05, 2024

Vol.50 No.01

Letter To The Editor

The field of population epigenetics is failing on rigor and reproducibility

To the editor, I was not booed off the stage. Rather, the response was incredibly enthusiastic. After my session people lined up for over 45 minutes to talk to me. Many thanked me for publicizing this issue, indicating that the problems with the Illumina platform have been apparent to many, but no one else was...

December 08, 2023

Vol.49 No.45

In Brief

UF Health Cancer Center to launch mobile mammography unit and expand access to care

For many individuals living in the rural 23-county area of North Central Florida served by the UF Health Cancer Center, access to mammography services for breast cancer screening is limited.

December 08, 2023

Vol.49 No.45

Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics

YOU MAY BE INTERESTED IN

Pan-cancer proteogenomics reveals potential drug targets

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

Kristin Heath named executive director of the UF Health Proton Therapy Institute

The field of population epigenetics is failing on rigor and reproducibility

UF Health Cancer Center to launch mobile mammography unit and expand access to care

Renew today!

Subscriber content

Login